Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Bel Marra Health Reports on New Research Discovered Pigs as an Alternative to Organ Donation in Diabetes
  • USA - English


News provided by

Belmarra Nutritionals, Inc

Jul 13, 2013, 07:00 ET

Share this article

Share toX

Share this article

Share toX

Bel Marra Health Reports on New Research Discovered Pigs as an Alternative to Organ Donation in Diabetes
Bel Marra Health Reports on New Research Discovered Pigs as an Alternative to Organ Donation in Diabetes

Chicago, IL;Houston, TX;Los Angeles-Long Beach, CA;New York, NY;Washington, DC (PRWEB) July 13, 2013 -- Bel Marra Health, who offers high-quality, specially formulated vitamins and nutritional supplements, reports on a new study revealing a new method for organ transplants in diabetes patients.

The researchers injected stem cells taken from rats into the embryos of mice that were unable to grow their own pancreas.

Post this

As Bel Marra Health reports in its article, (http://www.belmarrahealth.com/diabetes-2/could-pigs-be-the-cure-for-diabetes/), currently, close to 30 million people in the United States have diabetes. While treatment for this disease has come a long way, the condition still makes it difficult for the sufferer's pancreas to produce insulin. This requires many people to seek out an organ transplant for survival - currently, over 115,000 people in the United States are in need of an organ transplant. But, sadly, severe shortages in available organs force patients to wait a very long time before they are able to receive the replacements they need; some lose their lives while they are waiting.

However, Japanese and American researchers believe that they are on their way to solving this problem once and for all, treading into new territory that was once the stuff of science-fiction movies. While previous studies have already shown astonishing success when pig cells were injected into human diabetic patients, researchers now claim to be close to growing entirely functional human organs inside the bodies of pig hosts.

Although controversial, the science of cloning may one day be able to help cure diabetes, eliminating the desperation of people on the organ donor waiting list. Experts at the Centre for Stem Cell Biology and Regenerative Medicine at the University of Tokyo believe that, with more research, they are close to generating functional human organs using the same technique they have applied to animals.

The researchers injected stem cells taken from rats into the embryos of mice that were unable to grow their own pancreas. When the mice grew, they developed a fully functional pancreas and, as adults, had no signs of diabetes. The scientists believe that almost any organ could be produced in this way. If the experiment was conducted using human stem cells, it could potentially produce a way of treating diabetic patients by providing a replacement pancreas.

For ethical reasons, humans are not an option when it comes to this type of research experiment - but, because of human genetic similarities, pigs may just be. Scientists have already been able to produce pigs that can generate human blood. They did this by injecting human blood cells into a pig fetus. Essentially, scientists are now saying that it is possible that, one day, human organs could be grown inside pigs in a similar fashion, to then be used in transplant operations.

This isn’t the first time scientists have looked at pigs as a way to help humans cure diabetes. A few years ago in New Zealand, at least a dozen people had pig cells injected into them to help control their type-1 diabetes. Two of the patients reported that they were soon able to completely stop their use of injected insulin. Eight others were able to stop the usage of insulin for several months at a time. A remaining few were more concerned that this treatment could lead to the transmission of viruses from pigs, and so refused to participate in the study. Australia put a ban on the practice of pig cell injections; however, that ban has now been lifted. Scientists in New Zealand say that all animals must be free of disease before being considered for such studies.

In the United States, the University of Minnesota and the Mayo Clinic have joined forces to find a cure for diabetes. Researchers at the University believe that pigs have genetic characteristics that are “remarkably” similar to human beings. The University and the Mayo Clinic are now involved in two experiments in their quest to fight the disease. One study is taking cells from pigs raised in germ-free pens, while the other study uses cells from human skin. The University researchers say there is potential that, one day, pigs could provide an unlimited supply of pancreatic insulin-producing cells to diabetic patients.

While optimistic about the future role that pigs will play in fighting diabetes, researchers admit that there is a lot of work to be done, and federal support will be required before humans can reap any possible benefits.

(SOURCE: Gray, Richard. "Pigs Could Grow Human Organs in Stem Cell Breakthrough." The Telegraph. N.p., 19 June 2013.)

Bel Marra Health is the maker of “Glucose Control Formula,” a high-quality nutritional supplement that helps support healthy glucose metabolism, reduce blood fats, and promotes healthy blood sugar. All ingredients are backed with scientific evidence. Every product is tested for safety, quality, and purity at every stage of the manufacturing process. Furthermore, Bel Marra Health products are produced only in Health Canada approved facilities, going the extra mile to ensure that our health-conscious customers are getting top quality products. For more information on Bel Marra Health visit http://www.belmarrahealth.com or call 1-866-531-0466.

Jim Chiang, Belmarra Nutritionals, Inc, http://www.belmarrahealth.com/, 866-531-0466, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.